These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22803153)

  • 1. Cytochrome P450 2D6 polymorphism is a molecular genetic marker of liver cirrhosis progression.
    Nepomnyashchikh DL; Vavilin VA; Aidagulova SV; Makarova SI; Karavaeva YY; Shchepotina EG; Postnikova OA; Nokhrina ZhV; Vinogradova EV; Lyakhovich VV
    Bull Exp Biol Med; 2012 Mar; 152(5):633-6. PubMed ID: 22803153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAs as Potential Biomarkers for Viral Hepatitis B and C.
    Loureiro D; Tout I; Narguet S; Benazzouz SM; Mansouri A; Asselah T
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33327640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.
    Fishman S; Lurie Y; Peretz H; Morad T; Grynberg E; Blendis LM; Leshno M; Brazowski E; Rosner G; Halpern Z; Oren R
    Liver Int; 2006 Apr; 26(3):279-84. PubMed ID: 16584388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
    Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
    Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study.
    Yan LB; Rao HY; Ma YJ; Bai L; Chen EQ; Du LY; Yang RF; Wei L; Tang H;
    BMJ Open; 2016 Oct; 6(10):e012016. PubMed ID: 27733412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan population.
    Rebbani K; Ezzikouri S; Marchio A; Ababou M; Kitab B; Dejean A; Kandil M; Pineau P; Benjelloun S
    Infect Genet Evol; 2014 Aug; 26():1-7. PubMed ID: 24797387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathomorphological study of HCV antibody-positive liver cirrhosis.
    Shimamatsu K; Kage M; Nakashima O; Kojiro M
    J Gastroenterol Hepatol; 1994; 9(6):624-30. PubMed ID: 7532451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of cirrhosis after chronic hepatitis B].
    Hazama H; Koga M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():354-7. PubMed ID: 15453345
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic variants in IL33 and IL1RL1 genes confer susceptibility to HBV-related liver cirrhosis in Chinese Han population.
    Ma N; Xu M; Dong Y; Yu F; Zhang X; Gao X; Meng Y; Gao P; Zhou J; Yuan M; Mi Y; Qi S; Li L; Liu D; Liu W; Yang L
    Infect Genet Evol; 2021 Oct; 94():104983. PubMed ID: 34197916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
    Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
    Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGF and P75NTR gene expression is associated with the hepatic fibrosis stage due to viral and non-viral causes.
    Amoras Eda S; Gomes ST; Freitas FB; Santana BB; Ishak G; de Araújo MT; Demachki S; da Silva Conde SR; de Oliveira Guimarães Ishak M; Ishak R; Vallinoto AC
    PLoS One; 2015; 10(3):e0121754. PubMed ID: 25816145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
    Wirtz TH; Fischer P; Backhaus C; Bergmann I; Brandt EF; Heinrichs D; Koenen MT; Schneider KM; Eggermann T; Kurth I; Stoppe C; Bernhagen J; Bruns T; Fischer J; Berg T; Trautwein C; Berres ML
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression.
    Shackel NA; McGuinness PH; Abbott CA; Gorrell MD; McCaughan GW
    Am J Pathol; 2002 Feb; 160(2):641-54. PubMed ID: 11839585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis/cirrhosis after orthotopic liver transplantation.
    Tabatabai L; Lewis WD; Gordon F; Jenkins R; Khettry U
    Hum Pathol; 1999 Jan; 30(1):39-47. PubMed ID: 9923925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.
    van Dekken H; Wink J; Alers JC; de Man RA; IJzermans JN; Zondervan PE
    Acta Histochem; 2003; 105(1):29-41. PubMed ID: 12666986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A candidate gene study for the association of host single nucleotide polymorphisms with liver cirrhosis risk in chinese hepatitis B patients.
    Peng L; Guo J; Zhang Z; Liu L; Cao Y; Shi H; Wang J; Wang J; Friedman SL; Sninsky JJ
    Genet Test Mol Biomarkers; 2013 Sep; 17(9):681-6. PubMed ID: 23844940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation.
    Zimmermann T; Hoppe-Lotichius M; Körner A; Lautem A; Heise M; Foltys D; Weiler N; Biesterfeld S; Schmidtmann I; Galle PR; Otto G; Schuchmann M
    Transpl Int; 2011 Nov; 24(11):1059-67. PubMed ID: 21797939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic biomarkers for hepatocellular cancer risk in a caucasian population.
    De Mattia E; Cecchin E; Polesel J; Bignucolo A; Roncato R; Lupo F; Crovatto M; Buonadonna A; Tiribelli C; Toffoli G
    World J Gastroenterol; 2017 Sep; 23(36):6674-6684. PubMed ID: 29085212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.